MX2016016836A - Metodos y dispositivos para tratar trastornos oculares posteriores. - Google Patents

Metodos y dispositivos para tratar trastornos oculares posteriores.

Info

Publication number
MX2016016836A
MX2016016836A MX2016016836A MX2016016836A MX2016016836A MX 2016016836 A MX2016016836 A MX 2016016836A MX 2016016836 A MX2016016836 A MX 2016016836A MX 2016016836 A MX2016016836 A MX 2016016836A MX 2016016836 A MX2016016836 A MX 2016016836A
Authority
MX
Mexico
Prior art keywords
end portion
devices
medicament container
methods
medicament
Prior art date
Application number
MX2016016836A
Other languages
English (en)
Inventor
White Daniel
Noronha Glenn
Victor Andino Rafael
John Brooks Christopher
Patel Samirkumar
Original Assignee
Clearside Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clearside Biomedical Inc filed Critical Clearside Biomedical Inc
Publication of MX2016016836A publication Critical patent/MX2016016836A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a métodos y dispositivos para tratar uveítis, edema macular asociado con uveities y edema macular asociado con oclusión de vena retinal en un sujeto humano en necesidad del mismo. En ciertos aspectos, los dispositivos proporcionados en la presente incluyen un recipiente de medicamento que define un lumen configurado para contener un medicamento, una porción de extremo distal del recipiente de medicamento que incluye una porción de acoplamiento configurada para que se acople de forma removible a un montaje de aguja, una porción de extremo proximal del recipiente de medicamenteo que incluye una pestaña y un resalto longitudinal; un montaje de pistón que incluye una porción de extremo distal colocada de forma movible dentro del lumen del recipiente de medicamento; y un mango acoplado a una porción de extremo proximal del montaje de pistón.
MX2016016836A 2014-06-17 2015-06-17 Metodos y dispositivos para tratar trastornos oculares posteriores. MX2016016836A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201462013209P 2014-06-17 2014-06-17
US201462018148P 2014-06-27 2014-06-27
US201462063792P 2014-10-14 2014-10-14
US201562155367P 2015-04-30 2015-04-30
US201562156802P 2015-05-04 2015-05-04
PCT/US2015/036299 WO2015195842A1 (en) 2014-06-17 2015-06-17 Methods and devices for treating posterior ocular disorders

Publications (1)

Publication Number Publication Date
MX2016016836A true MX2016016836A (es) 2017-07-27

Family

ID=54936084

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016836A MX2016016836A (es) 2014-06-17 2015-06-17 Metodos y dispositivos para tratar trastornos oculares posteriores.

Country Status (12)

Country Link
US (1) US20180042765A1 (es)
EP (1) EP3157463A4 (es)
JP (2) JP6774340B2 (es)
KR (1) KR102511477B1 (es)
CN (1) CN107072765A (es)
AU (1) AU2015277133A1 (es)
BR (1) BR112016029864A2 (es)
CA (1) CA2952822A1 (es)
IL (1) IL249602A0 (es)
MX (1) MX2016016836A (es)
RU (1) RU2017101236A (es)
WO (1) WO2015195842A1 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
WO2012051575A2 (en) 2010-10-15 2012-04-19 Iscience Interventional Corporation Device for ocular access
SG11201503637SA (en) 2012-11-08 2015-06-29 Clearside Biomedical Inc Methods and devices for the treatment of ocular diseases in human subjects
KR102282973B1 (ko) 2013-05-03 2021-07-27 클리어사이드 바이오메디컬, 인코포레이드 안구용 주사를 위한 장치 및 방법
WO2014197317A1 (en) 2013-06-03 2014-12-11 Clearside Biomedical, Inc. Apparatus and methods for drug delivery using multiple reservoirs
EP4555981A3 (en) 2014-02-12 2025-08-06 Genentech, Inc. Method and apparatus for suprachoroidal administration of therapeutic agent
US9925088B2 (en) 2014-06-06 2018-03-27 Janssen Biotech, Inc. Sub-retinal tangential needle catheter guide and introducer
US9949874B2 (en) 2014-06-06 2018-04-24 Janssen Biotech, Inc. Therapeutic agent delivery device with convergent lumen
RU2710491C2 (ru) 2014-06-20 2019-12-26 Клиасайд Байомедикал, Инк. Устройство для инъекции лекарственного средства в глазную ткань и способ инъекции лекарственного средства в глазную ткань
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
US10219936B2 (en) 2014-09-11 2019-03-05 Orbit Biomedical Limited Therapeutic agent delivery device with advanceable cannula and needle
US10258502B2 (en) 2014-09-18 2019-04-16 Orbit Biomedical Limited Therapeutic agent delivery device
TWI761959B (zh) * 2014-11-07 2022-04-21 瑞士商諾華公司 治療眼部疾病之方法
BR112018013407A2 (en) 2015-12-30 2018-12-18 Kodiak Sciences Inc. antibodies and conjugates thereof
CN108778330A (zh) * 2016-01-08 2018-11-09 科尼尔赛德生物医学公司 用阿柏西普和其他生物制品治疗后眼部障碍的方法和装置
EP3448495A4 (en) 2016-01-19 2020-02-12 Dr. Py Institute, LLC DEVICES AND METHODS FOR FORMULATION PROCESSING
US10390901B2 (en) 2016-02-10 2019-08-27 Clearside Biomedical, Inc. Ocular injection kit, packaging, and methods of use
US10478553B2 (en) 2016-03-09 2019-11-19 Orbit Biomedical Limited Apparatus for subretinal administration of therapeutic agent via a curved needle
WO2017192565A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
US10806629B2 (en) 2016-06-17 2020-10-20 Gyroscope Therapeutics Limited Injection device for subretinal delivery of therapeutic agent
US11000410B2 (en) 2016-06-17 2021-05-11 Gyroscope Therapeutics Limited Guide apparatus for tangential entry into suprachoroidal space
US10646374B2 (en) 2016-06-17 2020-05-12 Orbit Biomedical Limited Apparatus and method to form entry bleb for subretinal delivery of therapeutic agent
IL264764B2 (en) 2016-08-12 2024-02-01 Clearside Biomedical Inc Devices and methods for adjusting the insertion depth of a drug administration needle
US11273072B2 (en) 2017-01-13 2022-03-15 Gyroscope Therapeutics Limited Suprachoroidal injection device
AU2018230478B2 (en) 2017-03-09 2025-01-23 Diamedica Inc. Dosage forms of tissue kallikrein 1
US11076984B2 (en) 2017-03-13 2021-08-03 Gyroscope Therapeutics Limited Method of performing subretinal drainage and agent delivery
WO2018204515A1 (en) 2017-05-02 2018-11-08 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle
WO2019133690A1 (en) * 2017-12-28 2019-07-04 Nichiban Co., Ltd. Transdermal drug delivery system and method for using same
WO2019161272A1 (en) 2018-02-15 2019-08-22 North Carolina State University Synthesis of micron and nanoscale carbon spheres and structures using hydrothemal carbonization
SG11202008242XA (en) 2018-03-02 2020-09-29 Kodiak Sciences Inc Il-6 antibodies and fusion constructs and conjugates thereof
WO2019173211A1 (en) * 2018-03-05 2019-09-12 Massachusetts Eye And Ear Infirmary Amelioration of autoimmune uveitis through blockade of csf1r
WO2019217678A1 (en) * 2018-05-09 2019-11-14 North Carolina State University Applicator for corneal therapeutics
US11039954B2 (en) * 2019-03-21 2021-06-22 Microoptx Inc. Implantable ocular drug delivery devices and methods
CN110009626A (zh) * 2019-04-11 2019-07-12 北京百度网讯科技有限公司 用于生成图像的方法和装置
KR20220019667A (ko) 2019-04-16 2022-02-17 클리어사이드 바이오메디컬, 인코포레이드 주사 가능한 트리암시놀론 제형
KR20250051157A (ko) 2019-06-05 2025-04-16 리제너론 파아마슈티컬스, 인크. 정밀 투여량 전달을 위한 디바이스 및 방법
US11912784B2 (en) 2019-10-10 2024-02-27 Kodiak Sciences Inc. Methods of treating an eye disorder
CN115697333A (zh) * 2020-02-19 2023-02-03 科尼尔赛德生物医学公司 包含阿西替尼的组合物和治疗眼部疾病的方法
JP7636517B2 (ja) * 2020-07-17 2025-02-26 エスエイチエル・メディカル・アーゲー マイクロ投薬デバイス、および、マイクロ投薬デバイスの組み立ての方法
US20240000443A1 (en) * 2020-11-30 2024-01-04 Visionaire Products, Inc. Needle and collection device for ocular biopsy and methods of use
CN116829150A (zh) * 2020-12-02 2023-09-29 泰利奥斯制药公司 用于治疗眼部病况的方法和组合物
CA3202582A1 (en) * 2020-12-17 2022-06-23 Edward J. Timm Injection apparatus and method of use
CN113101502B (zh) * 2021-03-01 2023-01-17 李特 一种耳鼻喉科用治疗装置
CN113198003A (zh) * 2021-06-22 2021-08-03 万永年 一种用于皮肤损伤后预防萎缩性疤痕外用液及其制备方法
US20250177417A1 (en) * 2022-01-06 2025-06-05 Clearside Biomedical, Inc. Compositions and methods for treating macular edema associated with uveitis
TWI890114B (zh) * 2022-08-16 2025-07-11 美商奧伊斯特普安生物製藥公司 將藥物無菌地轉移至藥物遞送裝置的藥物轉移系統及方法
WO2024064848A2 (en) * 2022-09-23 2024-03-28 Inoculus Ventures, Inc. Dry eye treatment
US12370201B2 (en) * 2023-07-10 2025-07-29 Eden Ophthalmic Pte Ltd. Liposomal formulations of corticosteroids and uses thereof
WO2025179248A1 (en) * 2024-02-23 2025-08-28 Oculogenex Inc. Microneedle device for intraocular injections and methods of using the same
WO2026003765A1 (en) 2024-06-25 2026-01-02 Kiniksa Pharmaceuticals, Gmbh Formulations of anti-interleukin 1 receptor 1 antibodies

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2951938B1 (ja) * 1998-03-19 1999-09-20 日本ケミカルリサーチ株式会社 薬剤溶解機構を内蔵した注射器
US20050101582A1 (en) * 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
CA2553381C (en) * 2004-01-20 2011-03-22 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US8685435B2 (en) * 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US20070202186A1 (en) * 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
CA2670990A1 (en) * 2006-12-01 2008-06-12 Allergan, Inc. Method for determining optimum intraocular locations for drug delivery systems
US8083759B2 (en) * 2007-11-02 2011-12-27 Refocus Ocular, Inc. Apparatuses and methods for forming incisions in ocular tissue
US8221353B2 (en) * 2008-10-21 2012-07-17 KMG Pharma, Inc Intravitreal injection device and system
WO2012019136A2 (en) * 2010-08-05 2012-02-09 Forsight Vision 4, Inc. Injector apparatus and method for drug delivery
US20120101475A1 (en) * 2010-10-21 2012-04-26 Meridian Medical Technologies, Inc. High Efficiency Auto-Injector
EP2578260A1 (en) * 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Apparatus for intraocular injection
SG11201503637SA (en) * 2012-11-08 2015-06-29 Clearside Biomedical Inc Methods and devices for the treatment of ocular diseases in human subjects
WO2015095772A2 (en) * 2013-12-20 2015-06-25 Emory University Formulations and methods for targeted ocular delivery of therapeutic agents

Also Published As

Publication number Publication date
KR20170039128A (ko) 2017-04-10
RU2017101236A3 (es) 2019-05-16
JP6774340B2 (ja) 2020-10-21
WO2015195842A1 (en) 2015-12-23
US20180042765A1 (en) 2018-02-15
AU2015277133A1 (en) 2017-02-02
CA2952822A1 (en) 2015-12-23
IL249602A0 (en) 2017-02-28
EP3157463A4 (en) 2018-02-21
CN107072765A (zh) 2017-08-18
RU2017101236A (ru) 2018-07-17
BR112016029864A2 (pt) 2017-08-22
JP2020063236A (ja) 2020-04-23
KR102511477B1 (ko) 2023-03-16
EP3157463A1 (en) 2017-04-26
JP2017524677A (ja) 2017-08-31

Similar Documents

Publication Publication Date Title
MX2016016836A (es) Metodos y dispositivos para tratar trastornos oculares posteriores.
MX2018008469A (es) Metodos y dispositivos para tratar trastornos oculares posteriores con aflibercept y otros productos biologicos.
Delplace et al. Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions
SG191334A1 (en) Use of a vegf antagonist to treat angiogenic eye disorders
MX2016016070A (es) Introductor y guia de cateter con aguja tangencial subretinal.
PH12017500460A1 (en) Therapeutic agent delivery device with advanceable cannula and needle
CL2017001117A1 (es) Métodos para tratar enfermedades oculares.
PH12015502773A1 (en) Methods for treating or preventing opthalmological conditions
BR112018012182A2 (pt) dispositivo para tratamento fotodinâmico
MY192241A (en) An injector docking device
NZ701069A (en) Methods and devices for drug delivery to ocular tissue using microneedle
MX360016B (es) Prenda de compresion medica terapeutica y metodo.
MX2019013799A (es) Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.
PH12014500967A1 (en) A medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent
MX2018001918A (es) Aplicación cuantitativa periorbital de farmacos oftalmologicos.
PL3128968T3 (pl) Strój do leczenia skórnych i podskórnych zaburzeń tkankowych oraz regeneracji sportowej, zawierający cylindryczny korpus
MX2016016090A (es) Composicion oftalmica para el tratamiento de infeccion ocular.
MX2015014939A (es) Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias e hipertension.
NZ729181A (en) Treatment of disease with poly-n-acetylglucosamine nanofibers
MX2017015664A (es) Administracion intravenosa de citrulina durante cirugia.
GB201210464D0 (en) Implantable medical device
BR112017007102A2 (pt) uso de um medicamento no tratamento de patologias da córnea, composição oftálmica para uso de um medicamento no tratamento de doenças da córnea e método para preparar a composição oftálmica
NZ740722A (en) Oral suspension for treating eosinophilic esophagitis
MX351710B (es) Dispositivo auxiliar para el manejo de jeringas tipo carpule durante el procedimiento de anestesia odontológica.
Nordin et al. Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia